Charles Schwab Investment Management Inc Oragenics Inc Transaction History

Charles Schwab Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.24 - $0.42 $24,186 - $42,326	100,778 New	100,778 $35,000
Q2 2021 Aug 16, 2021	SELL	$0.6 - $0.89 $25,527 - $37,865	-42,545 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.52 - $1.52 $22,123 - $64,668	42,545 New	42,545 $39,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.